Related Experiment Video
Updated: Oct 6, 2025

A Modified Sonographic Algorithm for Image Acquisition in Life-Threatening Emergencies in the Critically Ill Newborn
Published on: April 7, 2023
Congenital junctional ectopic tachycardia in the paediatric emergency department
Danyal Memon1, Elizabeth Larkin1, Mathew Varghese1
1Department of Paediatrics, Our Lady of Lourdes Hospital, Drogheda, Ireland.
Insights
Congenital junctional ectopic tachycardia (CJET) is a serious infant heart condition. This case study explores ivabradine as a potential treatment for CJET, which often resists standard therapies.
Area of Science:
- Pediatric Cardiology
- Neonatal Medicine
- Cardiac Electrophysiology
Background:
- Congenital junctional ectopic tachycardia (CJET) is a rare and severe cardiac arrhythmia in neonates.
- CJET presents significant management challenges due to resistance to conventional treatments like cardioversion and adenosine.
- High rates of morbidity and mortality are associated with untreated or refractory CJET.
Purpose of the Study:
- To present a case of CJET in a 14-day-old neonate.
- To highlight the efficacy and role of ivabradine in managing refractory CJET.
- To discuss contemporary treatment strategies for congenital junctional ectopic tachycardia.
Main Methods:
- Case report of a neonate diagnosed with CJET.
- Administration of ivabradine for arrhythmia management.
- Review of current literature and treatment guidelines for CJET.
Main Results:
- The neonate presented with symptoms consistent with CJET.
- Ivabradine was utilized as a therapeutic intervention.
- The case highlights a potential alternative or adjunctive therapy for refractory CJET.
Conclusions:
- CJET requires prompt and effective management strategies.
- Ivabradine shows promise as a treatment option for neonates with refractory CJET.
- Further research is warranted to establish ivabradine's role in CJET management.
Abstract:
Congenital junctional ectopic tachycardia is a rare but serious cardiac arrhythmia seen in neonates and young infants. It is frequently resistant and refractory to first-line treatment options such as cardioversion with adenosine and direct current shock, and it carries a high morbidity and mortality rate. The aim of this article is to present the case of congenital junctional ectopic tachycardia observed in a 14-day-old neonate, highlighting the role of ivabradine in the management, followed by a discussion about current approaches to treatment.
Related Concept Videos
Dysrhythmias III: Characteristics of Dysrhythmias
Dysrhythmias II: Classification of Tachyarrhythmias
Increased pulse rate
Many factors can elevate the risk of developing tachycardia. These include advanced age, a family history of arrhythmias, and an...
Disturbances in Heart Rhythm
Arrhythmias are categorized by their speed, rhythm, and origin. A slow heart...
ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias
Dysrhythmias IV: Characteristics of Bradyarrhythmias

